title: [Toxic epidermal necrolysis with fatal ending due to the concurrent use of carbamazepine, cilostazol and omeprazol: a case report].
authors.forename: I
authors.initials: I
authors.lastname: Concepción Martín
authors.forename: M A
authors.initials: MA
authors.lastname: Fernández de Palencia Espinosa
authors.forename: B
authors.initials: B
authors.lastname: Garrido Corro
authors.forename: A
authors.initials: A
authors.lastname: De La Rubia Nieto
mesh_terms: D000368:Aged; D001189:Aryl Hydrocarbon Hydroxylases / Q000037:antagonists & inhibitors / Q000378:metabolism; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D000077407:Cilostazol; D065731:Cytochrome P-450 CYP2C19; D051544:Cytochrome P-450 CYP3A / Q000378:metabolism; D004347:Drug Interactions; D004790:Enzyme Induction / Q000187:drug effects; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D009853:Omeprazole / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D011282:Pregnenediones / Q000627:therapeutic use; D012148:Restless Legs Syndrome / Q000188:drug therapy; D012772:Shock, Septic / Q000150:complications; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy / Q000209:etiology*; D013469:Sulpiride / Q000008:administration & dosage / Q000627:therapeutic use; D013777:Tetrazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D014202:Tremor / Q000188:drug therapy; D014581:Urticaria / Q000139:chemically induced
chemical_list: D011282:Pregnenediones; D013777:Tetrazoles; D002220:Carbamazepine; D013469:Sulpiride; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; D009853:Omeprazole; C021988:deflazacort; D000077407:Cilostazol; D008775:Methylprednisolone